Tuesday, 31 March 2020

Australia News

  • Allied sales rise 13% to $3.7 mn in H2, 2012

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 22 Feb, 2013

    Singapore: Australia-based Allied Healthcare has marked a stronger sales with revenues up at 13 percent to $3.7 million for six months ending December 31, 2012, as compared to $3.319 millio...Read more

  • Australia launches nanotech R&D plan

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 07 Dec, 2012

    Singapore: Senator Kate Lundy, the Australian minister assisting for industry and innovation,  has launched Australian Academy of Science's National Nanotechnology Research Strategy. Prep...Read more

  • AtCor wins $1.1 mn contract for SphygmoCor system

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 21 Aug, 2012

    Singapore: Australian firm AtCor Medical, a developer and marketer of the SphygmoCor system that measures central aortic blood pressures and arterial stiffness noninvasively, has signed a ...Read more

  • ResMed launches sleep apnea device in the US

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jun, 2012

    Singapore: ResMed, Australian developer, manufacturer and distributor of sleep and respiratory medical equipment, has launched Narval CC, its state-of-the-art mandibular repositioning devi...Read more

  • Invida gets COPD drug rights in Australia, NZ

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 17 Oct, 2012

    Singapore: Almirall granted commercial rights for Aclidinium in Australia and New Zealand for the treatment of chronic obstructive pulmonary disorder (COPD) to Invida Holdings. Although th...Read more

  • Viralytics commences trading on US OTCQX

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 05 Aug, 2013

    Singapore: Viralytics' American Depository Receipts (ADRs) have commenced trading on OTCQX International. ADRs trade under the symbol 'VRACY' and each ADR represents three ordinary shares. ...Read more

  • Allied applies for heart patch approval in US

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 02 Apr, 2013

    Singapore: Allied Healthcare has lodged its Premarket Notification 510(k) Submission for CardioCel in the US. The FDA 510(K) submission is a major step in Allied's strategy to gain marketin...Read more

  • Distinguished AIDS researcher, Prof Joep Lange, dies in MH17 crash

    Australia |  Influencers | By BioSpectrum Bureau  | 0 Comment | 18 Jul, 2014

    Singapore: Eminent AIDS researcher, Prof Joep Lange, died in the Malaysian Airlines flight MH17 crash on July 17 while he was enroute to Melbourne to attend 20th International AIDS Conferen...Read more

  • New tech promises revenue boost for drug makers

    Australia |  Influencers | By BioSpectrum Bureau  | 0 Comment | 12 Jun, 2013

    Australian drug delivery technology company Imugene has developed Linguet, a drug delivery technology platform, to improve efficacy and safety of existing prescriptions and over-the-counter...Read more

  • Mr Paul Wright, Universal Biosensors: Point-of-care-diagnostics will continue to grow in 2013

    Australia |  Opinion | By BioSpectrum Bureau  | 0 Comment | 26 Dec, 2012

    I think there will be continuing of existing trends in 2013 as well. We expect to see ongoing growth in the point-of-care-diagnostics (POCD) market. I also expect continued integration of d...Read more

  • World leader discuss health challenges at Qatar

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 11 Dec, 2013

    Singapore: World leaders and policy makers have gathered in Doha, Qatar, to discuss innovative solutions to the most pressing global health challenges at the inaugural World Innovation Summ...Read more

  • Aussie firm Mayne to acquire GSK's Kapanol

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 07 Jan, 2013

    Singapore: Australia's Mayne Pharma plans to acquire Kapanol and related assets in Australia from GlaxoSmithKline (GSK). Under the terms of the agreement, Mayne Pharma will acquire the Kap...Read more

  • Patrys progresses myeloma trial to patient group

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 18 Jan, 2013

    Singapore: Patrys, a clinical stage biopharmaceutical company, received approval to progress its phase I/IIa PAT-SM6 multiple myeloma trial based on safety data from its first group of pat...Read more

  • AtCor to report full year maiden profit

    Australia |  Company results | By BioSpectrum Bureau  | 0 Comment | 22 Jul, 2013

    Singapore: AtCor Medical, the developer and marketer of the SphygmoCor system that measures central blood pressures and arterial stiffness non-invasively, revealed unaudited FY2013 sales of...Read more

  • Starpharma's new condom gel will fight STIs

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 21 Jul, 2014

    Singapore: Australia's biotechnology company, Starpharma has received a regulatory approval for the sale of its revolutionary new product in the country. The company has developed a virus-...Read more

  • Russell Howard to join Prima BioMed board

    Australia |  Influencers | By BioSpectrum Bureau  | 0 Comment | 09 May, 2013

    Singapore: Prima BioMed has appointed Dr Russell J Howard as a non-executive director with immediate effect. Dr Howard brings a strong scientific background and significant executive-level ...Read more

  • Prana provides update on Huntington Disease trial

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 15 Nov, 2012

    Singapore: Melbourne-based Prana Biotechnology released an update on the Huntington Disease trial. The company reported the progress in the Reach2HD trial at the Huntington Study Group Annu...Read more

  • Starpharma to receive $6 mn for overseas R&D

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 23 Nov, 2012

    Singapore: Australia-based Starpharma is eligible to receive approximately $6 million cash in R&D tax incentives for overseas research activities related to VivaGel. Starpharma has made...Read more